Objective: The objective of this study was to analyze the expression of proliferative markers and p53 in keratocystic odontogenic tumor (KCOT) sporadic type and KCOT associated with nevoid basal cell carcinoma syndrome (NBCCS).
Study Design and Setting: We performed a cross-sectional study. A total of 19 patients with KCOT were selected from the Oral Pathology Laboratory archives, Central University of Venezuela, from 1995 to 2005.
Subjects and Methods: Twelve cases corresponded to sporadic KCOT, and seven cases were associated with NBCCS. Immunohistochemical analysis for p53, proliferating cell nuclear antigen (PCNA), and Ki-67 was performed in all 19 cases.
Results: Of the seven cases associated with NBCCS, six (86%) were positive for PCNA. From the 12 sporadic cases, nine (75%) were positive for PCNA. Only one case of sporadic KCOT showed Ki-67 positivity. Five of 12 (42%) cases of sporadic KCOT were positive for p53, and only one (14%) case associated with NBCCS was positive for p53.
Conclusion: On the basis of the analysis of the expression of PCNA, Ki-67, and p53, there appears to be no evidence to indicate higher aggressiveness in growth and infiltrative behavior in syndromic KCOT compared with the sporadic type. Therefore, surgical treatment may be approached in the same manner in KCOT sporadic and syndromic with the goal of minimizing recurrence.
Get full access to this article
View all access options for this article.
References
1.
. BarnesLEvesonJWReichartP, editors. World Health Organization classification of tumors. Pathology and genetics of head and neck tumors. Lyon: IARC Press; 2005.
. MadrasJLapointeH.Keratocystic odontogenic tumour: reclassification of the odontogenic keratocyst from cyst to tumour. J Can Dent Assoc2008;74:165–165h.
4.
. LiTJBrowneRMMatthewsJB.Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. J Oral Pathol Med1995;24:221–6.
5.
. KimiKKumamotoHOoyaK. Immunohistochemical analysis of cell-cycle- and apoptosis-related factors in lining epithelium of odontogenic keratocysts. J Oral Pathol Med2001;30:434–42.
6.
. ShearM.The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. Oral Oncol2002;38:323–31.
7.
. LombardiTOdellEWMorganPR.p53 immunohistochemistry of odontogenic keratocysts in relation to recurrence, basal-cell budding and basal-cell naevus syndrome. Arch Oral Biol1995;40:1081–4.
8.
. SlootwegPJ.p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. J Oral Pathol Med1995;24:393–7.
9.
. RiveraHCorrentiMAvilaM. Expression of PCNA, Ki-67, BCL2, and p53 in odontogenic cysts [abstract]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod2005;100:193.
10.
. el MurtadiAGrehanDTonerM. Proliferating cell nuclear antigen staining in syndrome and nonsyndrome odontogenic keratocysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod1996;81:217–20.
11.
. MeloESKawamuraJYAlvesCA. Imaging modality correlations of an odontogenic keratocyst in the nevoid basal cell carcinoma syndrome: a family case report. Oral Surg Oral Med Oral Path Oral Rad End2004;98:232–6.
12.
. MarxR SD.Contemporary oral and maxillofacial surgery. Chicago: Mosby; 2003. p. 509–604.
13.
. ThosapornWIamaroonAPongsiriwetS. A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma. Oral Dis2004;10:22–6.
14.
. KaplanIHirshbergA.The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. Oral Ocol2004;40:985–91.
15.
. de ManzoniGVerlatoGTomezzoliA. Study on Ki-67 immunoreactivity as a prognostic indicator in patients with advanced gastric cancer. Jpn J Clin Oncol1998;28:534–7.
16.
. PiattelliAFioroniMSantinelliA. p53 protein expression in odontogenic cysts. J Endod2001;27:459–61.
